Home | Welcome to Contract Pharma   
Last Updated Monday, June 1 2015

Print

Search Results for 'formulation'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 20, 2015
GEA Niro Mobile Minor enhances solutions for poorly soluble compounds Read More »
Published May 15, 2015
Publishes results from Enabled-First-in-Human program conducted for the Janssen WAVE Early Development unit. Read More »
2015 Annual Outsourcing Survey
By Tim Wright, Editor
Published May 13, 2015
Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers. Read More »
Published May 13, 2015
Offers improved compaction properties in direct compression applications Read More »
Published May 12, 2015
Gains softgel manufacturing technology Read More »
Published May 12, 2015
Gains leading biologic treatment and oncology infrastructure for $900M Read More »
Published May 8, 2015
Patheon gives you the most royalty-free options when it comes to complex formulations. This brochure highlights our various technolgies and dose form capabilities including multi-release options, taste masking and lyophilization.… Read More »
Published May 8, 2015
Patheon has developed over 80 large molecule dose forms. This sell sheet highlights Patheon's extensive experience and capabilities ranging from early formulation development through to product commercialization of both liquid and lyophilized product… Read More »
Published May 8, 2015
Patheon’s Pediatric Services are dedicated to developing palatable formulations, including oral liquids, chewable tablets, dispersible tablets, sachets, oral disintegrating tablets and softgels. This sell sheet discusses the interactions between AP… Read More »
Published May 8, 2015
The objective of this study was to determine critical process parameters which influence the characteristics of spray dried materials for quick small scale formulation screening using DOE. Different polymers (PVP-K30 in dichloromethane and HPMCAS LF… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the effect of lactose monohydrate of the tabletability performance of roller compacted blends a s a preliminary screening study towards development of a model for roller compaction formulations. The flowabili… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the effect of increasing aspirin content on the tabletability performance of roller compacted blends as part of a larger study towards development of a model for roller compaction formulations.… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the effect of increasing naproxen content on the tabletability performance of roller compacted blends as part of a larger study towards development of a model for roller compaction formulations. Compactibilit… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the effect of increasing ibuprofen content on the tabletability performance of roller compacted blends as part of a larger study towards development of a model for roller compaction formulations.… Read More »
Published May 8, 2015
The purpose of this study was to develop large diameter, non-disintegrating controlled-release tablet formulations using hydrophilic polymer matrix systems for pH sensitive low solubility drugs. The results indicated that interactions of drug, excipi… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the use of the hot melt granulation technique for improving dissolution and bioavailability of a poorly soluble API. Coating was achieved by adjusting the spray rate and inlet temperatures. The final formulat… Read More »
Published May 8, 2015
The goal of this study was to design a platform technology for a controlled release orally disintegrating tablet (ODT) using cationic ion exchange resins which will facilitate taste masking. Sodium polystyrene sulfonate, USP (AMBERLITETM IRP69) was u… Read More »
Published May 8, 2015
The purpose of this study was to determine critical process parameters which influence the characteristics of spray dried materials for quick small scale formulation screening using DOE. Cconcentration of the spray dry solution can significantly affe… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the incidence of cracking of gelatin capsules filled with commercially viable examples of hygroscopic placebo formulations and low viscosity hydrophobic liquids.… Read More »
Published May 8, 2015
The purpose of this study was to understand the roller compaction behavior of different model placebo formulations using smooth rolls and to compare their performance against different roll surfaces. This study clearly demonstrates the differences in… Read More »
Published May 8, 2015
The purpose of this study is to further optimize and assess the effect of refining magnesium stearate lubricant, sweetener, hardness and thickness levels on the design of a fast disintegrating formulation by direct compression.… Read More »
Published May 8, 2015
The purpose of this study was to establish the design space and operational conditions for the roller compaction process of a placebo formulation that closely represents a low-dose active formulation. The ribbon density, tensile strength, mean granul… Read More »
Published May 8, 2015
The purpose of this study was to evaluate the use of a true placebo DoE to create a platform process in which to define a viable active formulation process on a roller compactor. The use of placebo DoE was effective in creating a platform process for… Read More »
Published May 8, 2015
The purpose of this study was to investigate the effect of wet granulation factors on the compression behaviour and other physical characteristics of a slow release polymeric matrix formulation. The water quantity used for granulation was the most im… Read More »
Published May 8, 2015
The objective of this study was to achieve the drug release rate which is independent of time and the concentration from a solid oral tablet dosage form. A zero order, pH independent release formulation for a freely water soluble model drug (Buspiron… Read More »
Published May 8, 2015
A pharmaceutical company came to Patheon with a suspension formulation that’s high viscosity curtailed production speeds. We reengineered our manufacturing equipment to work efficiently with this specific product to increased throughput by four… Read More »
Published May 8, 2015
A large pharmaceutical company wanted to develop a bilayer tablet, each layer having different release profiles. One of the layers was low dose and moisture sensitive. There were also layer lamination issues during formulation development and in stor… Read More »
Published May 8, 2015
Patheon transferred a customer’s manufacturing process and delivered an improved formulation with better stability, scalability and manufacturability. We also prepared documentation for a robust CMC package for their NDA submission.… Read More »
Published May 8, 2015
The chemical structure of a customer’s new molecule indicated potential for oxidative degradation and hydrolysis. Through binary excipient compatibility testing, Patheon was able to focus efforts on a formulation with maximum stability.… Read More »
Published May 8, 2015
A new degradation product was observed in accelerated stability chromatograms for a new formulation. A tentative structural assignment was made by the customer's consultant but needed to be verified.… Read More »
Published May 8, 2015
A small biotech company was developing a compound with poor solubility and bioavailability. Patheon’s SoluPath™ parallel screening service quickly and cost-effectively determined the best formulation to overcome these issues.… Read More »
By Emil W. Ciurczak, DoraMaxx Consulting
Published May 6, 2015
Looking at standard methods and references Read More »
Published May 6, 2015
Catalent Completes $52M Expansion at Winchester, KY, Facility Read More »
Why is Good Tablet Design so Important and How to Achieve it?
By Steve Deakin and Steve Osborn , I Holland
Published May 6, 2015
Accuracy and tooling performance are essential for today’s complex profiles Read More »
How and When to Use Multiple Techniques in Biophysical Protein Characterization
By Inigo Rodriguez-Mendieta , SGS Life Science Services
Published May 6, 2015
The uses and misuses of orthogonality in aggregation studies Read More »
2015 Outsourcing Survey
By Tim Wright, Editor
Published May 6, 2015
Herein are the results of our 2015 Annual Outsourcing Survey, where we call on you, the readers, to help us benchmark the state of the pharmaceutical outsourcing industry. Read More »
Published May 5, 2015
Contract revenue up 47% in the quarter Read More »
Published May 5, 2015
To add commercial spray-drying capacity for inhalation technologies to treat
a wider range of diseases Read More »
Published April 23, 2015
Initiates Phase III Trial Read More »
Published April 21, 2015
Will evaluate Zydis Technology to develop thermo stable and cold-chain independent vaccines Read More »
Published April 17, 2015
Samcyprone used for the treatment of malignant melanoma stage IIb to IV Read More »
Published April 16, 2015
Enhancing Life in Every Single Dose Read More »
Catalent Completes Winchester Expansion
Published April 15, 2015
Meets demands for advanced solid manufacturing Read More »
Published April 14, 2015
Will partner to develop new compounds Read More »
Published April 14, 2015
Completes production of a commercial scale lot of EVK-001 in accordance with CMC Read More »
Published April 13, 2015
Diversifies development risk with second, complementary acute pain product Read More »
Published April 13, 2015
New website has been launched at www.juniperpharma.com Read More »
Published April 8, 2015
Drs. Rozenman and Holfinger to oversee Phase III trial of lead product, AR 101 Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On